Since we verified the positive correlation between high MACC1 expression and adverse clinical outcome in this meta-analysis, a well-designed trial with adequate sample size should be conducted for analysis of the impact of MACC1 expression on the survival of PC patients in the future. Here, MACC1 is linked to pachyonychia congenita.